170 related articles for article (PubMed ID: 18255220)
1. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging.
Sontum PC
Ultrasound Med Biol; 2008 May; 34(5):824-33. PubMed ID: 18255220
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Perfluorobutane after Intra-Venous Bolus Injection of Sonazoid in Healthy Chinese Volunteers.
Li P; Hoppmann S; Du P; Li H; Evans PM; Moestue SA; Yu W; Dong F; Liu H; Liu L
Ultrasound Med Biol; 2017 May; 43(5):1031-1039. PubMed ID: 28283327
[TBL] [Abstract][Full Text] [Related]
3. A respiration-metabolism chamber system and a GC-MS method developed for studying exhalation of perfluorobutane in rats after intravenous injection of the ultrasound contrast agent Sonazoid.
Uran S; Landmark K; Normann PT; Hals PA; Toft KG; Skotland T
J Pharm Biomed Anal; 2005 Sep; 39(3-4):746-51. PubMed ID: 15964732
[TBL] [Abstract][Full Text] [Related]
4. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres.
Kindberg GM; Tolleshaug H; Roos N; Skotland T
Cell Tissue Res; 2003 Apr; 312(1):49-54. PubMed ID: 12712317
[TBL] [Abstract][Full Text] [Related]
5. Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.
Toft KG; Hustvedt SO; Hals PA; Oulie I; Uran S; Landmark K; Normann PT; Skotland T
Ultrasound Med Biol; 2006 Jan; 32(1):107-14. PubMed ID: 16364802
[TBL] [Abstract][Full Text] [Related]
6. Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa.
Otani K; Kamiya A; Miyazaki T; Koga A; Inatomi A; Harada-Shiba M
Ultrasound Med Biol; 2019 Jun; 45(6):1455-1465. PubMed ID: 30857759
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver.
Watanabe R; Matsumura M; Munemasa T; Fujimaki M; Suematsu M
Invest Radiol; 2007 Sep; 42(9):643-51. PubMed ID: 17700280
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the fragmentation thresholds and inertial cavitation doses of different ultrasound contrast agents.
Chen WS; Matula TJ; Brayman AA; Crum LA
J Acoust Soc Am; 2003 Jan; 113(1):643-51. PubMed ID: 12558300
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury.
Miyazaki M; Kato M; Tanaka M; Tanaka K; Takao S; Kohjima M; Ito T; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
J Gastroenterol Hepatol; 2011 Dec; 26(12):1749-56. PubMed ID: 21615794
[TBL] [Abstract][Full Text] [Related]
10. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
[TBL] [Abstract][Full Text] [Related]
11. A New Method to Quantify Concentration of Microbubbles in Attenuating Media Using Bubble Destruction Curve Analysis of the Contrast-Enhanced Ultrasound.
Kamiyama N; Wakui N; Oguri T; Hashimoto H; Kanayama Y; Nagai H
Ultrasound Med Biol; 2019 Sep; 45(9):2485-2492. PubMed ID: 31239150
[TBL] [Abstract][Full Text] [Related]
12. In vitro analysis of ultrasound second generation contrast agent diluted in saline solution.
Goddi A; Novario R; Tanzi F; Di Liberto R; Nucci P
Radiol Med; 2004; 107(5-6):569-79. PubMed ID: 15195019
[TBL] [Abstract][Full Text] [Related]
13. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
Hatanaka K; Kudo M; Minami Y; Maekawa K
Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
[TBL] [Abstract][Full Text] [Related]
14. Quantification of phosphatidylserine, phosphatidic acid and free fatty acids in an ultrasound contrast agent by normal-phase high-performance liquid chromatography with evaporative light scattering detection.
Hvattum E; Uran S; Sandbaek AG; Karlsson AA; Skotland T
J Pharm Biomed Anal; 2006 Oct; 42(4):506-12. PubMed ID: 16762523
[TBL] [Abstract][Full Text] [Related]
15. The influence of acoustic transmit parameters on the destruction of contrast microbubbles in vitro.
Shi WT; Forsberg F; Vaidyanathan P; Tornes A; Østensen J; Goldberg BB
Phys Med Biol; 2006 Aug; 51(16):4031-45. PubMed ID: 16885622
[TBL] [Abstract][Full Text] [Related]
16. Hyperenhanced Rim Surrounding Liver Metastatic Tumors in the Postvascular Phase of Sonazoid-Enhanced Ultrasonography: A Histological Indication of the Presence of Kupffer Cells.
Tochio H; Sugahara M; Imai Y; Tei H; Suginoshita Y; Imawsaki N; Sasaki I; Hamada M; Minowa K; Inokuma T; Kudo M
Oncology; 2015; 89 Suppl 2():33-41. PubMed ID: 26584034
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver.
Watanabe R; Matsumura M; Chen CJ; Kaneda Y; Fujimaki M
Biol Pharm Bull; 2005 Jun; 28(6):972-7. PubMed ID: 15930729
[TBL] [Abstract][Full Text] [Related]
18. Effect of parenchymal uptake of perfluorobutane microbubbles (Sonazoid(®) ) on radiofrequency ablation of the liver: in vivo experimental study.
Min JH; Kim YS; Rhim H; Lee MW; Kang TW; Song KD; Lim HK
Liver Int; 2016 Aug; 36(8):1187-95. PubMed ID: 26835608
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound contrast agent Sonazoid for the diagnosis of hepatic epithelioid angiomyolipoma: a case report.
Huang Z; Xin JY; Li KY
BMC Gastroenterol; 2021 Dec; 21(1):487. PubMed ID: 34930133
[TBL] [Abstract][Full Text] [Related]
20. Dynamical analysis of the nonlinear response of ultrasound contrast agent microbubbles.
Carroll JM; Calvisi ML; Lauderbaugh LK
J Acoust Soc Am; 2013 May; 133(5):2641-9. PubMed ID: 23654372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
